Author | Year | Sample size | Modality | Name of lipid | Sample type | Up/Down | Remarks |
---|---|---|---|---|---|---|---|
Shimma [28] | 2007 | 1 | MALDI-MS | SM (16:0) | Tissue | Up | Diagnostic Factor |
Thomas [29] | 2013 | 3 | MALDI-MS | PE (38:6), PE (40:4) | Tissue | Up | Diagnostic Factor |
Figueiredo [30] | 2018 | 36 | MALDI-MS | Sphingolipids | Tissue | Up | Diagnostic Factor |
Glycerophospholipid | Prognostic Factor | ||||||
Present | 2020 | 75 | LC-ESI-MS | Mono-unsaturated fatty acid | Tissue | Up | Diagnostic Factor |